Skip to content

Mesa Laboratories MLAB Increase (Decrease) in Prepaid Expense

Increase (Decrease) in Prepaid Expense at other companies

TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's increase (decrease) in prepaid expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's increase (decrease) in prepaid expense?
Mesa Laboratories (MLAB) reported increase (decrease) in prepaid expense of -$2.15M in Q1 2026.
How has Mesa Laboratories's increase (decrease) in prepaid expense changed year-over-year?
Mesa Laboratories's increase (decrease) in prepaid expense decreased by 15228.6% year-over-year, from -$14K to -$2.15M.
What is the long-term trend for Mesa Laboratories's increase (decrease) in prepaid expense?
Over 3 years (2022 to 2026), Mesa Laboratories's increase (decrease) in prepaid expense has grown at a -45.5% compound annual growth rate (CAGR), from $3.76M to -$608K.